Clinical Trials Browser

Glioma × azeliragon × 30 days × Clear all

NCT06724926 2026-05-18

Concurrent Azeliragon With Craniospinal Irradiation

Phase 1 Active not recruiting

Glioma, Meningeal Carcinomatosis